Predictive power of C-reactive protein shifts based on cirrhosis or coronary disease
A new study reveals that the predictive power of key inflammatory markers, such as C-reactive protein, shifts fundamentally…
Comparative study finds higher rates of adverse events with ticagrelor
One year of treatment with either of two strong blood-thinning medications—ticagrelor and prasugrel—by people with type 1 or…